These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12453547)

  • 41. Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease.
    Howlett JG
    Can J Cardiol; 2014 May; 30(5 Suppl):S29-37. PubMed ID: 24750980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
    Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
    J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
    Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
    Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertension.
    Weiss RJ; Weber MA; Carr AA; Sullivan WA
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):667-76. PubMed ID: 17786067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nebivolol therapy improves QTc and QTcd parameters in heart failure patients.
    Aksoy SM; Cay S; Cagirci G; Sen N
    Cardiovasc J Afr; 2012 May; 23(4):191-3. PubMed ID: 22614660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status.
    Acevedo M; Corbalán R; Chamorro G; Jalil J; Nazzal C; Campusano C; Castro P
    Int J Cardiol; 2003 Feb; 87(2-3):185-91. PubMed ID: 12559539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical use of Nebivolol in the treatment of chronic heart failure.
    Liberopoulos EN; Elisaf MS
    Hellenic J Cardiol; 2005; 46(3):208-11. PubMed ID: 15981556
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of left ventricular function and mitral regurgitation during left ventricular-based pacing in patients with heart failure.
    Etienne Y; Mansourati J; Touiza A; Gilard M; Bertault-Valls V; Guillo P; Boschat J; Blanc JJ
    Eur J Heart Fail; 2001 Aug; 3(4):441-7. PubMed ID: 11511430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hemodynamic effects of the beta blocker nebivolol].
    Rosenkranz S; Erdmann E
    Internist (Berl); 2003 Apr; 44(4):481-2. PubMed ID: 12914405
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of nebivolol in patients with idiopathic pulmonary hypertension: results of the pilot study].
    Martyniuk TV; Konosova ID; Chazova IE
    Ter Arkh; 2012; 84(12):49-53. PubMed ID: 23479989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subacute hemodynamic effects of nebivolol in man at rest and during exercise.
    De Crée J; Geukens H; Cobo C; Verhaegen H
    Angiology; 1987 Jun; 38(6):440-8. PubMed ID: 2884904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
    Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
    Pitt B; White H; Nicolau J; Martinez F; Gheorghiade M; Aschermann M; van Veldhuisen DJ; Zannad F; Krum H; Mukherjee R; Vincent J;
    J Am Coll Cardiol; 2005 Aug; 46(3):425-31. PubMed ID: 16053953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Diakakis GF; Chlouverakis GI; Vardas PE
    Am Heart J; 2005 Nov; 150(5):985. PubMed ID: 16290981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial.
    Montero-Perez-Barquero M; Flather M; Roughton M; Coats A; Böhm M; Van Veldhuisen DJ; Babalis D; Solal AC; Manzano L
    Eur J Heart Fail; 2014 Sep; 16(9):1009-15. PubMed ID: 25044535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
    Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Heart rate control with nebivolol in patients with tachysystolic atrial fibrillation].
    Shubik IuV; Medvedev MM; Kriatova TV
    Kardiologiia; 2003; 43(9):52-5. PubMed ID: 14593370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.